Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know
10:01am, Friday, 10'th Oct 2025
Recently, Zacks.com users have been paying close attention to Bristol Myers (BMY). This makes it worthwhile to examine what the stock has in store.
Bristol Myers buys Orbital Therapeutics for $1.5 billion
07:05am, Friday, 10'th Oct 2025
Drugmaker Bristol Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash.
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
06:59am, Friday, 10'th Oct 2025
PRINCETON, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #COBENFY--Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Campaign Spotlighting the Power of Support and Connection.
Bristol-Myers Squibb: Your Chance To Buy A Bargain 6% Yield
12:00pm, Thursday, 09'th Oct 2025
Bristol-Myers Squibb offers a compelling value at current lows, trading at under 7x earnings and yielding an attractive 6% dividend. BMY's resilient business model, strong cash flow, and growth from n
Can BMYs Neuroscience Portfolio Help to Diversify Its Business?
12:01pm, Wednesday, 08'th Oct 2025
Bristol Myers gains FDA Fast Track status for its Alzheimer's antibody BMS-986446 as Cobenfy drives early sales and pipeline momentum.
Why Bristol Myers Squibb (BMY) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 08'th Oct 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Bristol Myers Squibb (BMY) Registers a Bigger Fall Than the Market: Important Facts to Note
06:46pm, Tuesday, 07'th Oct 2025
In the closing of the recent trading day, Bristol Myers Squibb (BMY) stood at $44.66, denoting a -1.06% move from the preceding trading day.
Billionaires Are Piling Into United Health Group and These 2 Stocks
09:35am, Tuesday, 07'th Oct 2025
UnitedHealth Group (NYSE:UNH ), Bristol-Myers Squibb (NYSE:BMY) and Fiserv (NYSE:FI) have been getting plenty of attention from big name investors.
My Top 5 Biotech Stocks Big Pharma Could Buy Next
01:29pm, Monday, 06'th Oct 2025
While AI hype reigns on Wall Street, the healthcare sector is still far from the peaks it reached during the COVID-19 pandemic. And what's more important, many of the biotech stocks remain outside of
Final Trade: GDX, PFE, GFS, BMY
06:32pm, Wednesday, 01'st Oct 2025
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Alzheimers--BMS's Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer's Disease.
Bristol Myers, Takeda to pool data for AI-based drug discovery
05:31am, Wednesday, 01'st Oct 2025
Bristol Myers Squibb , Takeda Pharmaceuticals and Astex Pharmaceuticals are coming together to share proprietary data for training an artificial intelligence model to assist drug discovery and develop
Bristol Myers Squibb (BMY) Beats Stock Market Upswing: What Investors Need to Know
06:45pm, Tuesday, 30'th Sep 2025
Bristol Myers Squibb (BMY) reached $45.1 at the closing of the latest trading day, reflecting a +2.15% change compared to its last close.
3 Pharma Stocks Getting an Intraday Trump Bump
03:19pm, Tuesday, 30'th Sep 2025
Pharmaceutical stocks are enjoying tailwinds today, after President Donald Trump announced the launch of a direct-to-consumer website dubbed "TrumpRX.
